Inflammatory and bone remodeling responses to the cytolethal distending toxins

Cells

Volumn 3, Issue 2, 2014, Pages 236-246

  Belibasakis, Georgios N ^a   Bostanci, Nagihan ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Aggregatibacter actinomycetemcomitans; Bone remodeling; Campylobacter Jejuni; Cytokine; Cytolethal distending toxin; Haemophilus ducreyi; Helicobacter hepaticus; Immune response; Inflammation

Indexed keywords

CYTOKINE; CYTOLETHAL DISTENDING TOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; BONE REMODELING; CAMPYLOBACTER JEJUNI; CHRONIC HEPATITIS; COLITIS; CYTOKINE PRODUCTION; GENE EXPRESSION; HAEMOPHILUS DUCREYI; HELICOBACTER HEPATICUS; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; OSTEOLYSIS; PERIODONTITIS; REVIEW;

EID: 84927771814     PISSN: None     EISSN: 20734409     Source Type: Journal    
DOI: 10.3390/cells3020236     Document Type: Review

References (46)

1. Guerra, L.; Cortes-Bratti, X.; Guidi, R.; Frisan, T. The biology of the cytolethal distending toxins. Toxins (Basel) 2011, 3, 172-190.
2. Heywood, W.; Henderson, B.; Nair, S.P. Cytolethal distending toxin: Creating a gap in the cell cycle. J. Med. Microbiol. 2005, 54, 207-216.
3. Guerra, L.; Guidi, R.; Frisan, T. Do bacterial genotoxins contribute to chronic inflammation, genomic instability and tumor progression? FEBS J. 2011, 278, 4577-4588.
4. Smith, J.L.; Bayles, D.O. The contribution of cytolethal distending toxin to bacterial pathogenesis. Crit. Rev. Microbiol. 2006, 32, 227-248.
5. Kumar, H.; Kawai, T.; Akira, S. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 2011, 30, 16-34.
6. Vladimer, G.I.; Marty-Roix, R.; Ghosh, S.; Weng, D.; Lien, E. Inflammasomes and host defenses against bacterial infections. Curr. Opin. Microbiol. 2013, 16, 23-31.
7. Johansson, A. Aggregatibacter actinomycetemcomitans leukotoxin: A powerful tool with capacity to cause imbalance in the host inflammatory response. Toxins (Basel) 2011, 3, 242-259.
8. Henderson, B.; Ward, J.M.; Ready, D. Aggregatibacter (actinobacillus) actinomycetemcomitans: A triple a* periodontopathogen? Periodontol 2000 2010, 54, 78-105.
9. Shenker, B.J.; McKay, T.; Datar, S.; Miller, M.; Chowhan, R.; Demuth, D. Actinobacillus actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a g2 arrest in human T cells. J. Immunol. 1999, 162, 4773-4780.
10. Sato, T.; Koseki, T.; Yamato, K.; Saiki, K.; Konishi, K.; Yoshikawa, M.; Ishikawa, I.; Nishihara, T. P53-independent expression of p21(cip1/waf1) in plasmacytic cells during g(2) cell cycle arrest induced by actinobacillus actinomycetemcomitans cytolethal distending toxin. Infect. Immun. 2002, 70, 528-534.
11. Akifusa, S.; Poole, S.; Lewthwaite, J.; Henderson, B.; Nair, S.P. Recombinant actinobacillus actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis. Infect. Immun. 2001, 69, 5925-5930.
12. DiRienzo, J.M.; Song, M.; Wan, L.S.; Ellen, R.P. Kinetics of kb and hep-2 cell responses to an invasive, cytolethal distending toxin-producing strain of actinobacillus actinomycetemcomitans. Oral Microbiol. Immunol. 2002, 17, 245-251.
13. Belibasakis, G.; Johansson, A.; Wang, Y.; Claesson, R.; Chen, C.; Asikainen, S.; Kalfas, S. Inhibited proliferation of human periodontal ligament cells and gingival fibroblasts by actinobacillus actinomycetemcomitans: Involvement of the cytolethal distending toxin. Eur. J. Oral Sci. 2002, 110, 366-373.
14. Belibasakis, G.N.; Mattsson, A.; Wang, Y.; Chen, C.; Johansson, A. Cell cycle arrest of human gingival fibroblasts and periodontal ligament cells by actinobacillus actinomycetemcomitans: Involvement of the cytolethal distending toxin. APMIS 2004, 112, 674-685.
15. Darveau, R.P. Periodontitis: A polymicrobial disruption of host homeostasis. Nat. Rev. Microbiol. 2010, 8, 481-490.
16. Lerner, U.H. New molecules in the tumor necrosis factor ligand and receptor superfamilies with importance for physiological and pathological bone resorption. Crit. Rev. Oral Biol. Med. 2004, 15, 64-81.
17. Fernandes, K.P.; Mayer, M.P.; Ando, E.S.; Ulbrich, A.G.; Amarente-Mendes, J.G.; Russo, M. Inhibition of interferon-gamma-induced nitric oxide production in endotoxin-activated macrophages by cytolethal distending toxin. Oral Microbiol. Immunol. 2008, 23, 360-366.
18. Belibasakis, G.N.; Johansson, A.; Wang, Y.; Chen, C.; Lagergard, T.; Kalfas, S.; Lerner, U.H. Cytokine responses of human gingival fibroblasts to actinobacillus actinomycetemcomitans cytolethal distending toxin. Cytokine 2005, 30, 56-63.
19. Oscarsson, J.; Karched, M.; Thay, B.; Chen, C.; Asikainen, S. Proinflammatory effect in whole blood by free soluble bacterial components released from planktonic and biofilm cells. BMC Microbiol. 2008, 8, 206.
20. Belibasakis, G.N.; Johansson, A. Aggregatibacter actinomycetemcomitans targets nlrp3 and nlrp6 inflammasome expression in human mononuclear leukocytes. Cytokine 2012, 59, 124-130.
21. Schroder, K.; Tschopp, J. The inflammasomes. Cell 2010, 140, 821-832.
22. Mise, K.; Akifusa, S.; Watarai, S.; Ansai, T.; Nishihara, T.; Takehara, T. Involvement of ganglioside gm3 in g(2)/m cell cycle arrest of human monocytic cells induced by actinobacillus actinomycetemcomitans cytolethal distending toxin. Infect. Immun. 2005, 73, 4846-4852.
23. Akifusa, S.; Heywood, W.; Nair, S.P.; Stenbeck, G.; Henderson, B. Mechanism of internalization of the cytolethal distending toxin of actinobacillus actinomycetemcomitans. Microbiology 2005, 151, 1395-1402.
24. Yamada, T.; Komoto, J.; Saiki, K.; Konishi, K.; Takusagawa, F. Variation of loop sequence alters stability of cytolethal distending toxin (cdt): Crystal structure of cdt from actinobacillus actinomycetemcomitans. Protein Sci. 2006, 15, 362-372.
25. Cao, L.; Bandelac, G.; Volgina, A.; Korostoff, J.; DiRienzo, J.M. Role of aromatic amino acids in receptor binding activity and subunit assembly of the cytolethal distending toxin of aggregatibacter actinomycetemcomitans. Infect. Immun. 2008, 76, 2812-2821.
26. Li, L.; Ding, C.; Duan, J.L.; Yang, M.F.; Sun, Y.; Wang, X.Q.; Xu, Y. A new functional site w115 in cdta is critical for aggregatibacter actinomycetemcomitans cytolethal distending toxin. PLoS One 2013, 8, e65729.
27. Hughes, F.J.; Turner, W.; Belibasakis, G.; Martuscelli, G. Effects of growth factors and cytokines on osteoblast differentiation. Periodontol 2000 2006, 41, 48-72.
28. Blazkova, H.; Krejcikova, K.; Moudry, P.; Frisan, T.; Hodny, Z.; Bartek, J. Bacterial intoxication evokes cellular senescence with persistent DNA damage and cytokine signalling. J. Cell. Mol. Med. 2010, 14, 357-367.
29. Xu, T.; Lundqvist, A.; Ahmed, H.J.; Eriksson, K.; Yang, Y.; Lagergard, T. Interactions of haemophilus ducreyi and purified cytolethal distending toxin with human monocyte-derived dendritic cells, macrophages and cd4+ T cells. Microbes Infect. 2004, 6, 1171-1181.
30. Hickey, T.E.; McVeigh, A.L.; Scott, D.A.; Michielutti, R.E.; Bixby, A.; Carroll, S.A.; Bourgeois, A.L.; Guerry, P. Campylobacter jejuni cytolethal distending toxin mediates release of interleukin-8 from intestinal epithelial cells. Infect. Immun. 2000, 68, 6535-6541.
31. Li, Y.P.; Vegge, C.S.; Brondsted, L.; Madsen, M.; Ingmer, H.; Bang, D.D. Campylobacter jejuni induces an anti-inflammatory response in human intestinal epithelial cells through activation of phosphatidylinositol 3-kinase/akt pathway. Vet. Microbiol. 2011, 148, 75-83.
32. Elmi, A.; Watson, E.; Sandu, P.; Gundogdu, O.; Mills, D.C.; Inglis, N.F.; Manson, E.; Imrie, L.; Bajaj-Elliott, M.; Wren, B.W. et al. Campylobacter jejuni outer membrane vesicles play an important role in bacterial interactions with human intestinal epithelial cells. Infect. Immun. 2011, 80, 4089-4098.
33. Zheng, J.; Meng, J.; Zhao, S.; Singh, R.; Song, W. Campylobacter-induced interleukin-8 secretion in polarized human intestinal epithelial cells requires campylobacter-secreted cytolethal distending toxin- and toll-like receptor-mediated activation of nf-kappab. Infect. Immun. 2008, 76, 4498-4508.
34. Gerondakis, S.; Fulford, T.S.; Messina, N.L.; Grumont, R.J. Nf-kappab control of T cell development. Nat. Immunol. 2014, 15, 15-25.
35. Jones, M.A.; Totemeyer, S.; Maskell, D.J.; Bryant, C.E.; Barrow, P.A. Induction of proinflammatory responses in the human monocytic cell line thp-1 by campylobacter jejuni. Infect. Immun. 2003, 71, 2626-2633.
36. Hickey, T.E.; Majam, G.; Guerry, P. Intracellular survival of campylobacter jejuni in human monocytic cells and induction of apoptotic death by cytholethal distending toxin. Infect. Immun. 2005, 73, 5194-5197.
37. Young, V.B.; Knox, K.A.; Pratt, J.S.; Cortez, J.S.; Mansfield, L.S.; Rogers, A.B.; Fox, J.G.; Schauer, D.B. In vitro and in vivo characterization of helicobacter hepaticus cytolethal distending toxin mutants. Infect. Immun. 2004, 72, 2521-2527.
38. Pratt, J.S.; Sachen, K.L.; Wood, H.D.; Eaton, K.A.; Young, V.B. Modulation of host immune responses by the cytolethal distending toxin of helicobacter hepaticus. Infect. Immun. 2006, 74, 4496-4504.
39. Ge, Z.; Feng, Y.; Whary, M.T.; Nambiar, P.R.; Xu, S.; Ng, V.; Taylor, N.S.; Fox, J.G. Cytolethal distending toxin is essential for helicobacter hepaticus colonization in outbred swiss webster mice. Infect. Immun. 2005, 73, 3559-3567.
40. Ge, Z.; Rogers, A.B.; Feng, Y.; Lee, A.; Xu, S.; Taylor, N.S.; Fox, J.G. Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell. Microbiol. 2007, 9, 2070-2080.
41. Bostanci, N.; Ilgenli, T.; Emingil, G.; Afacan, B.; Han, B.; Toz, H.; Atilla, G.; Hughes, F.J.; Belibasakis, G.N. Gingival crevicular fluid levels of rankl and opg in periodontal diseases: Implications of their relative ratio. J. Clin. Periodontol. 2007, 34, 370-376.
42. Bostanci, N.; Ilgenli, T.; Emingil, G.; Afacan, B.; Han, B.; Toz, H.; Berdeli, A.; Atilla, G.; McKay, I.J.; Hughes, F.J. et al. Differential expression of receptor activator of nuclear factor-kappab ligand and osteoprotegerin mrna in periodontal diseases. J. Periodontal. Res. 2007, 42, 287-293.
43. Bostanci, N.; Saygan, B.; Emingil, G.; Atilla, G.; Belibasakis, G.N. Effect of periodontal treatment on receptor activator of nf-kappab ligand and osteoprotegerin levels and relative ratio in gingival crevicular fluid. J. Clin. Periodontol. 2011, 38, 428-433.
44. Belibasakis, G.N.; Bostanci, N. The rankl-opg system in clinical periodontology. J. Clin. Periodontol. 2012, 39, 239-248.
45. Belibasakis, G.N.; Johansson, A.; Wang, Y.; Chen, C.; Kalfas, S.; Lerner, U.H. The cytolethal distending toxin induces receptor activator of nf-kappab ligand expression in human gingival fibroblasts and periodontal ligament cells. Infect. Immun. 2005, 73, 342-351.
46. Belibasakis, G.N.; Brage, M.; Lagergard, T.; Johansson, A. Cytolethal distending toxin upregulates rankl expression in jurkat t-cells. APMIS 2008, 116, 499-506.